Midis mission is to revolutionize healthcare for women at midlife, wherever they live and whatever their health story
By acting on both GLP-1 and GIP receptors, tirzepatide offers an even more potent effect on appetite suppression and blood sugar regulation, often resulting in greater weight loss compared to semaglutide in clinical trials
According to research published in Cell Reports Medicine in 2026 by Langer et al., the answer is no
Weight loss compounds present a fundamental problem: they typically require much larger doses to be effective than can realistically be delivered through the skin
The bad news is that for the foreseeable future, consumers will continue to pay high prices, and employers are likely to continue to be more circumspect about coverage
Retatrutide includes this pathway but does not rely on it exclusively